ПРОФИЛАКТИКА И ЛЕЧЕНИЕ ОСТРОГО ПОВРЕЖДЕНИЯ ПОЧЕК ПРИ КАРДИОХИРУРГИЧЕСКИХ ОПЕРАЦИЯХ С ИСКУССТВЕННЫМ КРОВООБРАЩЕНИЕМ И ТРАНСПЛАНТАЦИИ СЕРДЦА

острое повреждение почек, кардиохирургия, предупреждение, заместительная почечная терапия

1. Tang A.T., El-Gamel A., Keevil B. et al. The effect of ‘renal-dose’ dopamine on renal tubular function follow- ing cardiac surgery: assessed by measuring retinol bind- ing protein (RBP) // Eur. J. Cardiothorac. Surg. 1999. Vol. 15. P. 717–721.

2. Woo E.B., Tang A.T., El-Gamel A. et al. Dopamine thera- py for patients at risk of renal dysfunction following cardiac surgery: science or fiction? // Eur. J. Cardiothorac.

3. Surg. 2002. Vol. 22. P. 106–111.

4. Dunning J., Khasati N., Barnard J. Low dose (renal

5. dose) dopamine in the critically ill patient // Interact.

6. Cardiovasc. Thorac. Surg. 2004. Vol. 3. P. 114–117.

7. Friedrich J.O., Adhikari N., Herridge M.S., Beyene J. Meta-analysis: low-dose dopamine increases urine out- put but does not prevent renal dysfunction or death //

8. Ann. Intern. Med. 2005. Vol. 142. Р. 510–520.

9. Stone G.W., McCullough P.A., Tumlin J.A. et al. Fenoldo- pam mesylate for the prevention of contrast-induced ne- phropathy: a randomized controlled trial // JAMA. 2003.

10. Vol. 290. P. 2284–2291.

11. Caimmi P.P., Pagani L., Micalizzi E. et al. Fenoldopam

12. for renal protection in patients undergoing cardiopul- monary bypass // J. Cardiothorac. Vasc. Anesth. 2003. Vol. 17. P. 491–494.

13. Garwood S., Swamidoss C., Davis E.A. et al. A case se- ries of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction // J. Car- diothorac. Vasc. Anesth. 2003. Vol. 17. P. 17–2l.

14. Ranucci M., Soro G., Barzaghi N. et al. Fenoldopam prophylaxis of postoperative acute renal failure in high- risk cardiac surgery patients // Ann. Thorac. Surg. 2004. Vol. 78. P. 1332–1337.

15. Bove T., Landoni G., Calabro M.G. et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, random- ized clinical trial // Circulation. 2005. Vol. 111. P. 3230– 3236.

16. Brienza N., Malcangi V., Dalfino L. et al. A comparison between fenoldopam and low-dose dopamine in early re- nal dysfunction of critically ill patients // Crit. Care Med. 2006. Vol. 34. P. 707–714.

17. Rosner M., Portilla D., Okusa M. Cardiac surgery as a cause of acute kidney injury: pathogenesis and potential therapies //J. Intensive Care. Med. 2008. Vol. 23. P. 3–18.

18. Kramer B.K., Preuner J., Ebenburger A. et al. Lack of renoprotective effect of theophylline during aortocoro- nary bypass surgery // Nephrol. Dial. Transplant. 2002. Vol. 17. P. 910–915.

19. Light D.B., Schwiebert E.M., Karlson K.H., Stanton B.A. Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells // Science. 1989. Vol. 243. P. 383–385.

20. Sward K., Valsson F., Odencrants P. et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo controlled trial // Crit. Care. Med. 2004. Vol. 32. P. 1310–1315.

21. Townsend D.R., Bagshaw S.M. New insights on intrave- nous fluids, diuretics and Acute Kidney Injury // Neph- ron. Clin. Pract. 2008. Vol. 109. P. 206–216.

22. Jarnberg P.O. Renal protection strategies in the peri- operative period // Best Pract. Res. Clin. Anaesthesiol. 2004. Vol. 18. P. 645–660.

23. Lassnigg A., Schmidlin D., Mouhieddine M. et al. Mini- mal changes of serum creatinine predict prognosis in pa- tients after cardiothoracic surgery: a prospective cohort study // J. Am. Soc. Nephrol. 2004. Vol. 15. P. 1597– 1605.

24. Uchino S., Doig G.S., Bellomo R. et al. Diuretics and mortality in acute renal failure // Crit. Care Med. 2004. Vol. 32:1669–1677.

25. Lombardi R., Ferreiro A., Servetto C. Renal function af- ter cardiac surgery: adverse effect of furosemide // Ren. Fail. 2003. Vol. 25. P. 775–786.

26. Mehta R.L, Pascual M.T, Soroko S., Chertow G.M. Di- uretics, mortality and nonrecovery of renal function in acute renal failure // JAMA. 2002. Vol. 288. P. 2547– 2553.

27. Cooper J.R., Giesecke N.M. Hemodilution and priming solutions // Gravlee G.P., Davis R.F., Kurusz M., Ut- ley J.R. eds. Cardiopulmonary Bypass: Principles and Practice. 2ns ed. Philadelphia: Lippincott, Williams & Wilkins. 2000. P. 186–196.

28. Fisher A.R., Jones P., Barlow P. et al. The influence of mannitol on renal function during and after open-heart surgery // Perfusion. 1998. Vol. 13. P. 181–186.

29. Carcoana O.V., Mathew J.P., Davis E. et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial // Anesth. Analg. 2003. Vol. 97. P. 1222–1229.

30. Smith M.N., Best D., Sheppard S.V., Smith D.C. The ef- fect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction // Anaesth. 2008. Vol. 63. P. 701–704.

31. Sirivella S., Gielchinsky I., Parsonnet V. Mannitol, fu- rosemide, and dopamine infusion in postoperative re- nal failure complicating cardiac surgery // Ann. Thorac. Surg. 2000. Vol. 69. P. 501–506.

32. Cagli K., Ulas M.M., Ozisik K. et al. The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass // Perfusion. 2005. Vol. 20. P. 45–51.

33. Zhang M., Xu Y.J., Saini H.K. et al. Pentoxifylline atten- uates cardiac dysfunction and reduces TNF-{alpha}level in the ischemic-reperfused heart // Am. J. Physiol. Heart. Circ. Physiol. 2005. Vol. 289. P. H832–H839.

34. Boldt J., Brosch C., Piper S.N. et al. Influence of prophy- lactic use of pentoxifylline on postoperative organ func- tion in elderly cardiac surgery patients // Crit. Care. Med. 2001. Vol. 29. P. 952–958.

35. Loef B.G., Henning R.H., Epema A.H. et al. Effect of dexamethasone on perioperative renal function impair- ment during cardiac surgery with cardiopulmonary by- pass // Br. J. Anaesth. 2004. Vol. 93. P. 793–798.

36. Shernan S.K., Fitch J.C., Nussmeier N.A. et al. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass // Ann. Thorac. Surg. 2004. Vol. 77. P. 942–949.

37. Sucu N., Cinel I., Unlu A. et al. N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass // Surg. Today. 2004. Vol. 34. P. 237–242.

38. Tossios P., Bloch W., Huebner A. et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial // Thorac. Cardiovasc. Surg. 2003. Vol. 126.

39. P. 1513–1520.

40. Kshirsagar A.V., Poole C., Mottl A. et al. N-acetylcys-

41. teine for the prevention of radiocontrast induced nephro- pathy: a meta-analysis of prospective controlled trials // J. Am. Soc. Nephrol. 2004. Vol. 15. P. 761–769.

42. Burns K.E., Chu M.W., Novick R.J. et al. Periopera- tive N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a ran- domized controlled trial // JAMA. 2005. Vol. 294. P. 342–349.

43. Jo S.K., Rosner M.H., Okusa M.D. Pharmacological treatment of acute kidney injury: why drugs have not worked and what is on the horizon // Clin. J. Am. Soc. Nephrol. 2007. Vol. 2. P. 356–365.

44. Awad A.S., Ye H., Huang L. et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-re- perfusion injury in mouse kidney // Am. J. Physial. Re- nal. Physiol. 2006. Vol. 290. P. F1516–F1524.

45. Li L., Okusa M.D. Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists // Nat. Clin. Pract. Nephrol. 2006. Vol. 2. P. 432–444.

46. Myles P.S., Hunt J.O., Holdgaard H.O. et al. Clonidine and cardiac surgery: haemodynamic and metabolic ef- fects, myocardial ischaemia and recovery // Anaesth. In- tensive Care. 1999. Vol. 27. P. 137–147.

47. Kulka P.J., Tryba M., Zenz M. Preoperative alpha2-ad- renergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a rando- mized, controlled trial // Crit. Care Med. 1996. Vol. 24. P. 947–952.

48. Chanda J., Canver C.C. Reversal of preexisting vasos- pasm in coronary artery conduits // Ann. Thorac. Surg. 2001. Vol. 72. P. 476–480.

49. Fansa I., Gol M., Nisanoglu V. et al. Does diltiazem in- hibit the inflammatory response in cardiopulmonary by- pass? // Med. Sci. Monit. 2003. Vol. 9. P. P130–P136.

50. Amar D., Fleisher M. Diltiazem treatment does not al- ter renal function after thoracic surgery // Chest. 2001. Vol. 119. P. 1476–1479.

51. Piper S.N., Kumle B., Maleck W.H. et al. Diltiazem may preserve renal tubular integrity after cardiac surgery // Can. J. Anaesth. 2003. Vol. 50. P. 285–292.

52. Young E.W., Diab A., Kirsh M.M. Intravenous diltiazem and acute renal failure after cardiac operations // Ann. Thorac. Surg. 1998. Vol. 65. P. 1316–1319.

53. Durmaz I., Yagdi T., Calkavur T. et al. Prophylactic di- alysis in patients with renal dysfunction undergoing on- pump coronary artery bypass surgery // Ann. Thorac. Surg. 2003. Vol. 75. P. 859–864.

54. Mehta R., McDonald B., Gabbai F. et al. Collaborative Group for Treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialy- sis for acute renal failure // Kidney. Int. 2001. Vol. 60. P. 1154–1163.

55. Teehan G., Liangos O., Lau J. et al. Dialysis membrane and modality in acute renal failure: understanding dis- cordant meta-analyses// Semin. Dial. 2003. Vol.16. P. 356–360.

56. Tonelli M., Manns B., Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery // Am. J. Kidney. Dis. 2002. Vol. 40. P. 875– 885.

57. Uehlinger D.E., Jakob S.M., Ferrari P. et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure // Nephrol. Dial. Transplant. 2005. Vol. 20(8). P. 1630–1637.

58. Van Biesen W., Vanholder R., Lameire N. Dialysis stra- tegies in critically ill acute renal failure patients // Curr. Opin. Crit. Care. 2003. Vol. 9. P. 491–495.

59. Ricci Z., Ronco C., D’amico G. et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey // Nephrol. Dial. Trans- plant. 2006. Vol. 21. P. 690–696.

60. Chang J., Yang W., Seo J. et al. Continuous veno-venous hemodiafiltration versus hemodialysis as renal replace- ment therapy in patients with acute renal failure in the intensive care unit // Scand. J. Urol. Nephrol. 2004. Vol. 38. P. 417–421.

61. De Vriese A., Vanholder R., Pascual M. et al. Can inflam- matory cytokines be removed efficiently by continuous renal replacement therapies? // Intens. Care. Med. 1999. Vol. 25. P. 903–910.

62. Fliser D., Kielstein J.T. A single-pass batch dialysis sy- stem: an ideal dialysis method for the patient in intensive care with acute renal failure // Curr. Opin. Crit. Care. 2004. Vol. 10. P. 483–488.

63. Cole L., Bellomo R., Journois D. et al. High-volume hae- mofiltration in human septic shock // Intens. Care. Med. 2001. Vol. 27. P. 978–986.

64. Kellum J., Mehta R., Angus D. et al. The first international consensus conference on соntinuous renal replacement therapy // Kidney. Int. 2002. Vol. 62. P. 1855–1863.

65. Ronco C., Bellomo R., Homel P. et al. Effects of different doses in continuous veno-venous haemofiltration on out- comes of acute renal failure: a prospective randomised trial // Lancet. 2000. Vol. 356. P. 26–30.

66. Schiffl H., Lang S.M., Fischer R. Daily hemodialysis and the outcome of acute renal failure // N. Engl. J. Med. 2002. Vol. 346. P. 305–310.

67. Saudan P., Niederberger M., De Seigneux S. et al. Ad- ding a dialysis dose to continuous hemofiltration increa- ses survival in patients with acute renal failure // Kidney. Int. 2006. Vol. 70. P. 1312–1317.

68. Faulhaber-Walter R., Hafer C., Jahr N. et al. The Han- nover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit // Nephrol. Dial. Transplant. 2009. Vol. 24(8). P. 2602.

69. Kumar V., Craig M., Depner Т., Yeun J. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit // Am. J. Kidney. Dis. 2000. Vol. 36. P. 294–300.

70. Kumar V., Yeun J., Depner Т. et al. Extended daily di- alysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report // Int. J. Artif. Organs. 2004. Vol. 27. P. 371–379.

71. Marshall M., Golper Т., Shaver M. et al. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy // Am. J. Kidney. Dis. 2002. Vol. 39. P. 556–570.

72. Marshall M., Ma T., Galler D. et al. Sustained low-ef- ficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy // Nephrol. Dial. Transplant. 2004. Vol. 19. P. 877–884.

73. Stevens L-M., El-Hamamsy I., Leblanc M. et al. Con- tinuous renal replacement therapy after heart transplan- tation // Can. J. Cardiol. 2004. Vol. 20 (6). P. 619–623.

74. Augustine J.J., Sandy D., Seifert T.H. et al. A randomised, controlled trial, comparing intermittent with continuous

75. veno-venous dialysis in patients with AKI // Am. J. Kid-

76. ney. Dis. 2004. Vol. 44. P. 1000–1007.

77. Lins R., Elseviers M., van der Niepen P. et al. Inter-

78. mittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the inten- sive care unit: results of a randomized clinical trial // Nephrol. Dial. Transplant. 2009. Vol. 24. P. 512– 518.

79. Vinsonneau C., Camus C., Comber A. et al. Continu- ous veno-venous haemofiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial // Lancet. 2006. Vol. 368. P. 379– 385.